Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
83
NPNKF Quote, Financials, Valuation and Earnings
Last price:
$30.51
Seasonality move
:
-8.27%
Day range:
$25.43 - $38.01
52-week range:
$21.00 - $41.82
Dividend yield:
2.74%
P/E ratio:
9.60x
P/S ratio:
1.91x
P/B ratio:
1.17x
Volume:
601
Avg. volume:
5K
1-year change:
-27.04%
Market cap:
$2.1B
Revenue:
$1.1B
EPS (TTM):
$3.18
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NPNKF
Nippon Shinyaku Co., Ltd.
|
-- | -- | -- | -- | -- |
|
HLOSF
Healios KK
|
-- | -- | -- | -- | -- |
|
PPTDF
PeptiDream Inc.
|
-- | -- | -- | -- | -- |
|
SOLTF
Nxera Pharma Co., Ltd.
|
-- | -- | -- | -- | -- |
|
STMM
Stemcell Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
TAK
Takeda Pharmaceutical Co., Ltd.
|
$7.8B | -- | -1.44% | -- | $17.76 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NPNKF
Nippon Shinyaku Co., Ltd.
|
$30.51 | -- | $2.1B | 9.60x | $0.42 | 2.74% | 1.91x |
|
HLOSF
Healios KK
|
$3.40 | -- | $392.4M | -- | $0.00 | 0% | 533.86x |
|
PPTDF
PeptiDream Inc.
|
$10.95 | -- | $1.4B | 13.79x | $0.00 | 0% | 11.79x |
|
SOLTF
Nxera Pharma Co., Ltd.
|
$5.00 | -- | $452.5M | -- | $0.00 | 0% | 2.34x |
|
STMM
Stemcell Holdings, Inc.
|
$0.06 | -- | $60M | -- | $0.00 | 0% | 0.17x |
|
TAK
Takeda Pharmaceutical Co., Ltd.
|
$14.31 | $17.76 | $45.2B | 181.60x | $0.34 | 4.65% | 1.54x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NPNKF
Nippon Shinyaku Co., Ltd.
|
0.96% | 0.055 | 1.07% | 3.49x |
|
HLOSF
Healios KK
|
47.23% | -1.205 | 3.71% | 1.23x |
|
PPTDF
PeptiDream Inc.
|
25.86% | 0.045 | 8.66% | 4.05x |
|
SOLTF
Nxera Pharma Co., Ltd.
|
49.02% | 1.721 | 73.82% | 2.21x |
|
STMM
Stemcell Holdings, Inc.
|
-- | 0.000 | -- | -- |
|
TAK
Takeda Pharmaceutical Co., Ltd.
|
39.45% | -0.605 | 68.02% | 0.64x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NPNKF
Nippon Shinyaku Co., Ltd.
|
$185.9M | $58.4M | 12.65% | 12.78% | 21.47% | $41.8M |
|
HLOSF
Healios KK
|
-$637.4K | -$5.2M | -86.08% | -194.37% | -4022.21% | -$5.3M |
|
PPTDF
PeptiDream Inc.
|
$11.3M | -$9.7M | -7.71% | -10.42% | -33.1% | -$12.5M |
|
SOLTF
Nxera Pharma Co., Ltd.
|
$27.7M | -$23.7M | -4.62% | -9.2% | -51.66% | -$20.9M |
|
STMM
Stemcell Holdings, Inc.
|
-- | -- | -- | -- | -- | -- |
|
TAK
Takeda Pharmaceutical Co., Ltd.
|
$3.6B | $763.2M | 0.33% | 0.55% | 10.11% | $2B |
Nippon Shinyaku Co., Ltd. vs. Competitors
-
Which has Higher Returns NPNKF or HLOSF?
Healios KK has a net margin of 18.72% compared to Nippon Shinyaku Co., Ltd.'s net margin of -9751.87%. Nippon Shinyaku Co., Ltd.'s return on equity of 12.78% beat Healios KK's return on equity of -194.37%.
Company Gross Margin Earnings Per Share Invested Capital NPNKFNippon Shinyaku Co., Ltd.68.38% $0.76 $1.8B HLOSFHealios KK-494.88% $0.03 $37.8M -
What do Analysts Say About NPNKF or HLOSF?
Nippon Shinyaku Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Healios KK has an analysts' consensus of -- which suggests that it could fall by --. Given that Nippon Shinyaku Co., Ltd. has higher upside potential than Healios KK, analysts believe Nippon Shinyaku Co., Ltd. is more attractive than Healios KK.
Company Buy Ratings Hold Ratings Sell Ratings NPNKFNippon Shinyaku Co., Ltd.0 0 0 HLOSFHealios KK0 0 0 -
Is NPNKF or HLOSF More Risky?
Nippon Shinyaku Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Healios KK has a beta of 0.210, suggesting its less volatile than the S&P 500 by 78.954%.
-
Which is a Better Dividend Stock NPNKF or HLOSF?
Nippon Shinyaku Co., Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 2.74%. Healios KK offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nippon Shinyaku Co., Ltd. pays 25.65% of its earnings as a dividend. Healios KK pays out -- of its earnings as a dividend. Nippon Shinyaku Co., Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios NPNKF or HLOSF?
Nippon Shinyaku Co., Ltd. quarterly revenues are $271.9M, which are larger than Healios KK quarterly revenues of $128.8K. Nippon Shinyaku Co., Ltd.'s net income of $50.9M is higher than Healios KK's net income of $3.8M. Notably, Nippon Shinyaku Co., Ltd.'s price-to-earnings ratio is 9.60x while Healios KK's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nippon Shinyaku Co., Ltd. is 1.91x versus 533.86x for Healios KK. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NPNKFNippon Shinyaku Co., Ltd.1.91x 9.60x $271.9M $50.9M HLOSFHealios KK533.86x -- $128.8K $3.8M
-
Which has Higher Returns NPNKF or PPTDF?
PeptiDream Inc. has a net margin of 18.72% compared to Nippon Shinyaku Co., Ltd.'s net margin of -25.38%. Nippon Shinyaku Co., Ltd.'s return on equity of 12.78% beat PeptiDream Inc.'s return on equity of -10.42%.
Company Gross Margin Earnings Per Share Invested Capital NPNKFNippon Shinyaku Co., Ltd.68.38% $0.76 $1.8B PPTDFPeptiDream Inc.38.71% -$0.06 $480.4M -
What do Analysts Say About NPNKF or PPTDF?
Nippon Shinyaku Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand PeptiDream Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Nippon Shinyaku Co., Ltd. has higher upside potential than PeptiDream Inc., analysts believe Nippon Shinyaku Co., Ltd. is more attractive than PeptiDream Inc..
Company Buy Ratings Hold Ratings Sell Ratings NPNKFNippon Shinyaku Co., Ltd.0 0 0 PPTDFPeptiDream Inc.0 0 0 -
Is NPNKF or PPTDF More Risky?
Nippon Shinyaku Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison PeptiDream Inc. has a beta of 0.569, suggesting its less volatile than the S&P 500 by 43.146%.
-
Which is a Better Dividend Stock NPNKF or PPTDF?
Nippon Shinyaku Co., Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 2.74%. PeptiDream Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nippon Shinyaku Co., Ltd. pays 25.65% of its earnings as a dividend. PeptiDream Inc. pays out -- of its earnings as a dividend. Nippon Shinyaku Co., Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios NPNKF or PPTDF?
Nippon Shinyaku Co., Ltd. quarterly revenues are $271.9M, which are larger than PeptiDream Inc. quarterly revenues of $29.3M. Nippon Shinyaku Co., Ltd.'s net income of $50.9M is higher than PeptiDream Inc.'s net income of -$7.4M. Notably, Nippon Shinyaku Co., Ltd.'s price-to-earnings ratio is 9.60x while PeptiDream Inc.'s PE ratio is 13.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nippon Shinyaku Co., Ltd. is 1.91x versus 11.79x for PeptiDream Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NPNKFNippon Shinyaku Co., Ltd.1.91x 9.60x $271.9M $50.9M PPTDFPeptiDream Inc.11.79x 13.79x $29.3M -$7.4M
-
Which has Higher Returns NPNKF or SOLTF?
Nxera Pharma Co., Ltd. has a net margin of 18.72% compared to Nippon Shinyaku Co., Ltd.'s net margin of -24.76%. Nippon Shinyaku Co., Ltd.'s return on equity of 12.78% beat Nxera Pharma Co., Ltd.'s return on equity of -9.2%.
Company Gross Margin Earnings Per Share Invested Capital NPNKFNippon Shinyaku Co., Ltd.68.38% $0.76 $1.8B SOLTFNxera Pharma Co., Ltd.60.42% -$0.13 $872.1M -
What do Analysts Say About NPNKF or SOLTF?
Nippon Shinyaku Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Nxera Pharma Co., Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Nippon Shinyaku Co., Ltd. has higher upside potential than Nxera Pharma Co., Ltd., analysts believe Nippon Shinyaku Co., Ltd. is more attractive than Nxera Pharma Co., Ltd..
Company Buy Ratings Hold Ratings Sell Ratings NPNKFNippon Shinyaku Co., Ltd.0 0 0 SOLTFNxera Pharma Co., Ltd.0 0 0 -
Is NPNKF or SOLTF More Risky?
Nippon Shinyaku Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Nxera Pharma Co., Ltd. has a beta of 0.029, suggesting its less volatile than the S&P 500 by 97.149%.
-
Which is a Better Dividend Stock NPNKF or SOLTF?
Nippon Shinyaku Co., Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 2.74%. Nxera Pharma Co., Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nippon Shinyaku Co., Ltd. pays 25.65% of its earnings as a dividend. Nxera Pharma Co., Ltd. pays out -- of its earnings as a dividend. Nippon Shinyaku Co., Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios NPNKF or SOLTF?
Nippon Shinyaku Co., Ltd. quarterly revenues are $271.9M, which are larger than Nxera Pharma Co., Ltd. quarterly revenues of $45.8M. Nippon Shinyaku Co., Ltd.'s net income of $50.9M is higher than Nxera Pharma Co., Ltd.'s net income of -$11.3M. Notably, Nippon Shinyaku Co., Ltd.'s price-to-earnings ratio is 9.60x while Nxera Pharma Co., Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nippon Shinyaku Co., Ltd. is 1.91x versus 2.34x for Nxera Pharma Co., Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NPNKFNippon Shinyaku Co., Ltd.1.91x 9.60x $271.9M $50.9M SOLTFNxera Pharma Co., Ltd.2.34x -- $45.8M -$11.3M
-
Which has Higher Returns NPNKF or STMM?
Stemcell Holdings, Inc. has a net margin of 18.72% compared to Nippon Shinyaku Co., Ltd.'s net margin of --. Nippon Shinyaku Co., Ltd.'s return on equity of 12.78% beat Stemcell Holdings, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital NPNKFNippon Shinyaku Co., Ltd.68.38% $0.76 $1.8B STMMStemcell Holdings, Inc.-- -- -- -
What do Analysts Say About NPNKF or STMM?
Nippon Shinyaku Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Stemcell Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Nippon Shinyaku Co., Ltd. has higher upside potential than Stemcell Holdings, Inc., analysts believe Nippon Shinyaku Co., Ltd. is more attractive than Stemcell Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NPNKFNippon Shinyaku Co., Ltd.0 0 0 STMMStemcell Holdings, Inc.0 0 0 -
Is NPNKF or STMM More Risky?
Nippon Shinyaku Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Stemcell Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock NPNKF or STMM?
Nippon Shinyaku Co., Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 2.74%. Stemcell Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nippon Shinyaku Co., Ltd. pays 25.65% of its earnings as a dividend. Stemcell Holdings, Inc. pays out -- of its earnings as a dividend. Nippon Shinyaku Co., Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios NPNKF or STMM?
Nippon Shinyaku Co., Ltd. quarterly revenues are $271.9M, which are larger than Stemcell Holdings, Inc. quarterly revenues of --. Nippon Shinyaku Co., Ltd.'s net income of $50.9M is higher than Stemcell Holdings, Inc.'s net income of --. Notably, Nippon Shinyaku Co., Ltd.'s price-to-earnings ratio is 9.60x while Stemcell Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nippon Shinyaku Co., Ltd. is 1.91x versus 0.17x for Stemcell Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NPNKFNippon Shinyaku Co., Ltd.1.91x 9.60x $271.9M $50.9M STMMStemcell Holdings, Inc.0.17x -- -- --
-
Which has Higher Returns NPNKF or TAK?
Takeda Pharmaceutical Co., Ltd. has a net margin of 18.72% compared to Nippon Shinyaku Co., Ltd.'s net margin of -1.05%. Nippon Shinyaku Co., Ltd.'s return on equity of 12.78% beat Takeda Pharmaceutical Co., Ltd.'s return on equity of 0.55%.
Company Gross Margin Earnings Per Share Invested Capital NPNKFNippon Shinyaku Co., Ltd.68.38% $0.76 $1.8B TAKTakeda Pharmaceutical Co., Ltd.47.41% -$0.03 $79.7B -
What do Analysts Say About NPNKF or TAK?
Nippon Shinyaku Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Takeda Pharmaceutical Co., Ltd. has an analysts' consensus of $17.76 which suggests that it could grow by 23.91%. Given that Takeda Pharmaceutical Co., Ltd. has higher upside potential than Nippon Shinyaku Co., Ltd., analysts believe Takeda Pharmaceutical Co., Ltd. is more attractive than Nippon Shinyaku Co., Ltd..
Company Buy Ratings Hold Ratings Sell Ratings NPNKFNippon Shinyaku Co., Ltd.0 0 0 TAKTakeda Pharmaceutical Co., Ltd.3 0 0 -
Is NPNKF or TAK More Risky?
Nippon Shinyaku Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Takeda Pharmaceutical Co., Ltd. has a beta of 0.027, suggesting its less volatile than the S&P 500 by 97.262%.
-
Which is a Better Dividend Stock NPNKF or TAK?
Nippon Shinyaku Co., Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 2.74%. Takeda Pharmaceutical Co., Ltd. offers a yield of 4.65% to investors and pays a quarterly dividend of $0.34 per share. Nippon Shinyaku Co., Ltd. pays 25.65% of its earnings as a dividend. Takeda Pharmaceutical Co., Ltd. pays out 242.25% of its earnings as a dividend. Nippon Shinyaku Co., Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Takeda Pharmaceutical Co., Ltd.'s is not.
-
Which has Better Financial Ratios NPNKF or TAK?
Nippon Shinyaku Co., Ltd. quarterly revenues are $271.9M, which are smaller than Takeda Pharmaceutical Co., Ltd. quarterly revenues of $7.5B. Nippon Shinyaku Co., Ltd.'s net income of $50.9M is higher than Takeda Pharmaceutical Co., Ltd.'s net income of -$79.5M. Notably, Nippon Shinyaku Co., Ltd.'s price-to-earnings ratio is 9.60x while Takeda Pharmaceutical Co., Ltd.'s PE ratio is 181.60x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nippon Shinyaku Co., Ltd. is 1.91x versus 1.54x for Takeda Pharmaceutical Co., Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NPNKFNippon Shinyaku Co., Ltd.1.91x 9.60x $271.9M $50.9M TAKTakeda Pharmaceutical Co., Ltd.1.54x 181.60x $7.5B -$79.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
65
Is AAPL Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
